Name:
Metformin tablets p / o 1000 mg in a cell. pack No. 10×3
Description:
Film-coated tablets with a biconvex surface, green; tablets with a dosage of 500 mg and 1000 mg – with a risk, a dosage of 850 mg – without a risk. The main active ingredient metformin hydrochloride Form of release Tablets Dosage 1000 mg Indications for use Type II diabetes mellitus (insulin-independent) with the ineffectiveness of diet therapy, especially in obese patients: – as monotherapy or combination therapy in conjunction with other oral hypoglycemic agents or in combination with insulin for the treatment of adults. – as monotherapy or combination therapy with insulin for the treatment of children over 10 years of age. Dosage and administration Monotherapy or combination therapy in conjunction with other oral hypoglycemic agents. Adults. The usual initial dose is 500 mg or 850 mg of metformin 2 to 3 times a day during or after meals. After 10 to 15 days of treatment, the dose must be adjusted according to the results of measurements of glucose levels in the blood serum. Gradual increase in dose helps to reduce side effects from the digestive tract. The maximum recommended dose is 3000 mg per day, divided into 3 doses. In the treatment of high doses, the drug Metformin, coated tablets 1000 mg, is used. In the case of switching to treatment with the drug Metformin, coated tablets, it is necessary to stop taking another antidiabetic agent. Contraindications – hypersensitivity to metformin and other biguanides; – diabetic ketoacidosis, diabetic precoma and coma; – chronic renal failure (with a serum creatinine level of more than 1.5 mg / dl in men and 1.4 mg / dl in women or creatinine clearance less than 60 ml / min); – violations of liver function (lack of liver function above II degree according to Child-Pugh); – conditions that can contribute to the development of lactic acidosis, incl. chronic heart failure, acute myocardial infarction, respiratory failure, acute cerebrovascular accident, dehydration, drinking with alcohol; – lactic acidosis (including history); – hypocaloric diet (less than 1000 kcal / day); – pregnancy and lactation; – children’s age up to 10 years; – the drug is not prescribed 2 days before surgery, radioisotope, x-ray studies with the introduction of contrast drugs and within 2 days after they are carried out; – acute conditions that occur with the risk of developing impaired renal function: dehydration of the body; fever, severe infectious diseases; clinical expression of manifestations of acute and chronic diseases that can lead to the development of tissue hypoxia (heart or respiratory failure, acute myocardial infarction, shock, sepsis, kidney infections, bronchopulmonary diseases); – acute alcohol intoxication, alcoholism; – serious surgical operations and injuries (when insulin therapy is indicated); – it is not recommended to use the drug in people over 60 years of age who perform heavy physical activity. Composition Each tablet contains: active ingredient – metformin hydrochloride – 500 mg or 850 mg, or 1000 mg; excipients – starch 1500 (corn starch partially pregelatinized), povidone, sodium croscarmellose, magnesium stearate, microcrystalline cellulose, opadry II (contains: polyvinyl alcohol, macrogol 3350, talc, titanium dioxide E 171, indigo carmine E 132, yellow quinoline E 104) . Buy Metformin tablets p/o 1000mg No. 10×3 Price for Metformin tablets p/o 1000mg No. 10×3
INN | METFORMIN |
---|---|
The code | 50 353 |
Barcode | 4 810 201 016 719 |
Dosage | 1000mg |
Active substance | Metformin |
Manufacturer | Borisovsky ZMP, Belarus |
Indications Applications | Diabetes mellitus type II (non-insulin dependent) with the ineffectiveness of diet therapy, especially in obese patients: – as monotherapy or combination therapy in conjunction with other oral hypoglycemic agents or in combination with insulin for the treatment of adults. – as monotherapy or combination therapy with insulin for the treatment of children over 10 years of age. |
Contraindications | hypersensitivity to metformin and other biguanides; – diabetic ketoacidosis, diabetic precoma and coma; – chronic renal failure (with a serum creatinine level of more than 1.5 mg / dl in men and 1.4 mg / dl in women or creatinine clearance less than 60 ml / min); – violations of liver function (lack of liver function above II degree according to Child-Pugh); – conditions that can contribute to the development of lactic acidosis, incl. chronic heart failure, acute myocardial infarction, respiratory failure, acute cerebrovascular accident, dehydration, drinking with alcohol; – lactic acidosis (including history); – hypocaloric diet (less than 1000 kcal / day); – pregnancy and lactation; – children's age up to 10 years; – the drug is not prescribed 2 days before surgery, radioisotope, x-ray studies with the introduction of contrast drugs and within 2 days after they are carried out; – acute conditions that occur with the risk of developing impaired renal function: dehydration of the body; fever, severe infectious diseases; clinical expression of manifestations of acute and chronic diseases that can lead to the development of tissue hypoxia (heart or respiratory failure, acute myocardial infarction, shock, sepsis, kidney infections, bronchopulmonary diseases); – acute alcohol intoxication, alcoholism; – serious surgical operations and injuries (when insulin therapy is indicated); – it is not recommended to use the drug in people over 60 years of age who perform heavy physical activity. |
Use during pregnancy and lactation | Forbidden to use |
Application Gender | Any |
Release Form | tablets |
Main Active Substances | metformin hydrochloride |
Composition Means | each tablet contains: active ingredient – metformin hydrochloride – 500 mg or 850 mg, or 1000 mg; excipients – starch 1500 (corn starch partially pregelatinized), povidone, sodium croscarmellose, magnesium stearate, microcrystalline cellulose, opadry II (contains: polyvinyl alcohol, macrogol 3350, talc, titanium dioxide E 171, indigo carmine E 132, yellow quinoline E 104) . |
Reviews
There are no reviews yet.